Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia

被引:39
|
作者
Abdel-Latif, Ahmed [1 ,2 ,3 ]
Zuba-Surma, Ewa K. [4 ,5 ]
Ziada, Khaled M. [1 ,2 ,3 ]
Kucia, Magdalena [4 ]
Cohen, Donald A. [6 ]
Kaplan, Alan M. [6 ]
Van Zant, Gary [7 ]
Selim, Samy [1 ,2 ,3 ]
Smyth, Susan S. [1 ,2 ,3 ]
Ratajczak, Mariusz Z. [4 ]
机构
[1] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Gill Heart Inst, Lexington, KY 40536 USA
[3] Lexington VA Med Ctr, Lexington, KY USA
[4] Univ Louisville, James Graham Brown Canc Ctr, Stem Cell Biol Inst, Louisville, KY 40292 USA
[5] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland
[6] Univ Kentucky, Dept Immunol Microbiol & Mol Genet, Lexington, KY 40536 USA
[7] Univ Kentucky, Lucille P Markey Canc Ctr, Div Hematol Oncol, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; VENTRICULAR EJECTION FRACTION; CARDIAC REPAIR; HEART-TRANSPLANTATION; PARACRINE MECHANISMS; INFARCTED MYOCARDIUM; MONONUCLEAR-CELLS; CD34(+) CELLS; CORD BLOOD;
D O I
10.1016/j.exphem.2010.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The [scheme myocardium releases multiple chemotactic factors responsible for the mobilization and recruitment of bone marrow derived cells to injured myocardium However, the mobilization of primitive pluripotent stem cells (PSCs) enriched in very small embryonic-like stem cells (VSELs) in various cardiac ischemic scenarios is not well understood Materials and Methods Fifty-four ischemic heart disease patients, including subjects with stable angina, non ST elevation myocardial infarction, and ST elevation myocardial infarction (STEMI) and 12 matched controls were enrolled The absolute numbers of circulating stem/primitive cells in samples of peripheral blood (PB) were quantitated by ImageStream analysis and conventional flow cytometry Gene expression of PSC (Oct-4 and Nanog), early cardiomyocyte (Nkx-2 5 and GATA-4), and endothelial (von Willebrand factor) markers was analyzed by real-time polymerase chain reaction Results The absolute numbers of PSCs, stem cell populations enriched in VSELs, and hematopoietic stem cells present in PB were significantly higher in STEMI patients at presentation and declined over time There was a corresponding increase in pluripotent, cardiac, and endothelial gene expression in unfractionated PB cells and sorted PB-derived primitive CD34(+) cells The absolute numbers of circulating VSELs and hematopmetic stem cells in STEMI correlated negatively with patient age Conclusions Myocardial ischemia mobilizes primitive PSCs including pluripotent VSELs into the circulation The peak of mobilization occurs within 12 hours in patients presenting with STEMI, which may represent a therapeutic window for future clinical applications Reduced stem cell mobilization with advancing age could explain, in part, the observation that age is associated with poor prognosis in patients with myocardial infarction Published by Elsevier Inc on behalf of the ISEH - Society for Hematology and Stem Cells
引用
收藏
页码:1131 / 1142
页数:12
相关论文
共 50 条
  • [1] Evidence of Mobilization of Pluripotent and Very Small Embryonic-Like (VSEL) Stem Cells in Patients with Myocardial Ischemia- A Potential Therapeutic Target
    Abdel-Latif, Ahmed
    Zuba-Surma, Ewa K.
    Kucia, Magdalena
    Ziada, Khaled M.
    Syed, Mushabbar A.
    Mukherjee, Debabrata
    Hamdalla, Hussam
    Smyth, Susan S.
    Ratajczak, Mariusz Z.
    CIRCULATION, 2008, 118 (18) : S538 - S538
  • [2] Mobilization of peripheral blood stem cells
    Arslan, Onder
    Moog, Rainer
    TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (02) : 179 - 185
  • [3] Mobilization of Mesenchymal Stem Cells into Peripheral Blood
    de la Cueva, Teresa
    Gutierrez, Ivan
    Ramirez, Manuel
    Zapata, Agustin
    Garcia-Castro, Javier
    HUMAN GENE THERAPY, 2009, 20 (09) : 1075 - 1075
  • [4] Mobilization of hematopoietic stem cells into the peripheral blood
    Damon, Lloyd E.
    Damon, Lauren E.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (06) : 717 - 733
  • [5] Mobilization of peripheral blood stem cells in patients with autoimmune disease.
    Burt, RK
    Burns, W
    Scheuning, F
    Schroeder, J
    Pope, R
    Cohen, B
    Karlin, K
    Lobeck, L
    Brush, M
    Fishman, H
    Welles, C
    Villa, M
    Shock, T
    Traynor, A
    BLOOD, 1999, 94 (10) : 330A - 330A
  • [6] Mobilization of peripheral blood stem cells : Tunisian experience
    Zriba, S.
    Ghedira, H.
    Kacem, K.
    Sakka, N.
    Ben Lakhal, R.
    Mansouri, R.
    Zarrouk, M.
    Maamer, M.
    Ben Abdennebi, Y.
    Ben Neji, H.
    Jeddi, R.
    Ali, Z. Belhadj
    Ben Abid, H.
    M'sadek, F.
    Hmida, S.
    Meddeb, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S524 - S524
  • [7] Peripheral blood stem cells PBSC mobilization.
    Fregatova, L
    Shavva, S
    Platonova, G
    Afanasiev, B
    BONE MARROW TRANSPLANTATION, 1998, 21 : S198 - S198
  • [8] Mobilization and Harvesting of Peripheral Blood Stem Cells in Pediatric Patients With Solid Tumors
    Veljkovic, Dobrila
    Vujic, Dragana
    Nonkovic, Olivera Serbic
    Jevtic, Dragana
    Zecevic, Zeljko
    Lazic, Emilija
    THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (06) : 579 - 586
  • [9] Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients
    Teusink, Ashley
    Pinkard, Susan
    Davies, Stella
    Mueller, Mark
    Jodele, Sonata
    TRANSFUSION, 2016, 56 (06) : 1402 - 1405
  • [10] Safety and Efficacy of Plerixafor for Mobilization of Peripheral Blood Stem Cells in Pediatric Patients
    Teusink, Ashley
    Pinkard, Sue L.
    Davies, Stella M.
    Mueller, Mark
    Jodele, Sonata
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S294 - S295